European Life Sciences Key IT Deals and Initiatives Update, Q2 2020

European Life Sciences Key IT Deals and Initiatives Update, Q2 2020

  • September 2020 •
  • 16 pages •
  • Report ID: 5962128 •
  • Format: PDF
This IDC Market Perspective provides IDC Health Insights' review of key IT deals, news, and digital initiatives in European life sciences and pharma in Q2 2020. In the unfolding scenario of COVID-19, it is critical for European life sciences companies and their technology suppliers to closely follow the fast-moving trends and developments to promptly spot favorable opportunities and remain competitive in the market during the crisis times and beyond. This is the eighth in the quarterly series of reports IDC Health Insights has released as it continues to provide in-depth research coverage of life sciences markets across Europe. "The COVID-19 pandemic has caused major disruptions in the life sciences industry across many business and therapeutic areas. At the same time, this crisis is pushing a paradigm shift in the uptake of information and communication technologies in healthcare and life sciences as never before. In the second quarter of 2020, life sciences organizations have been fast-tracking efforts across the whole value chain -- from R&D to production to distribution logistics -- to address the challenges created by the pandemic" -- Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe.